Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
This grant opportunity aims to support promising early-career researchers focused on the chemistry and pharmacology of substance use disorders. It targets those without preliminary data for an R01 grant but who propose impactful research and show leadership potential in the field. The grant encourages innovative research utilizing new methods and technologies to explore novel targets, mechanis…
oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impac…
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers